Vir Biotechnology, Inc. (VIR)
9.55
+0.45
(+4.95%)
USD |
NASDAQ |
Mar 06, 16:00
9.52
-0.03
(-0.31%)
After-Hours: 20:00
Vir Biotechnology Cash from Investing (TTM) : 310.37M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Hims & Hers Health, Inc. | -1.025B |
| BioMarin Pharmaceutical, Inc. | -414.24M |
| Xeris Biopharma Holdings, Inc. | -0.696M |
| Gossamer Bio, Inc. | 136.42M |
| Sensei Biotherapeutics, Inc. | 25.71M |